1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Omico: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients Tiragolumab, Atezolizumab - Solid Tumor, Adult | Phase 2 | Active not recruiting | Omico | 96 | 2023-12-15 | 2026-10-29 |
Tiragolumab (1) · atezolizumab (1)
Australia (1)